EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Osteopontin in Atrial Fibrillation and Atrial Remodeling

Argen Mamazhakypov, Balram Neupane iD, Akpay Sarybaev iD, Akylbek Sydykov iD, Ralph T Schermuly iD, Michael Gramlich, Kabita Pradhan iD

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.048418 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Argen Mamazhakypov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Institute for Lung Health, Cardio-Pulmonary Institute, Member of the German Center for Lung Research Justus Liebig U…. Hauptthemen laut MEDLINE: Osteopontin, Atrial Fibrillation, Atrial Remodeling, Heart Atria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation is the most prevalent sustained cardiac arrhythmia, characterized by limited therapeutic options because of incompletely understood mechanisms of its development. The key underlying pathogenetic mechanisms involve atrial myocardial inflammation and fibrosis in response to pressure or volume overload, myocardial infarction, as well as metabolic alterations. Recent studies have highlighted the crucial role of osteopontin in diverse cardiovascular diseases, including atrial fibrillation. Osteopontin is a multifunctional extracellular matrix protein that has recently emerged as a potential mediator of atrial remodeling and arrhythmogenesis. Human studies have revealed that circulating osteopontin levels can serve as a valuable biomarker for atrial fibrillation and its progression. Furthermore, in vitro studies have demonstrated that osteopontin modulates several key cellular processes involved in atrial inflammation and fibrosis, including fibroblast activation, extracellular matrix remodeling, and proinflammatory cytokine production. This review critically examines the available evidence on the role of osteopontin in atrial remodeling and arrhythmia starting from the molecular mechanisms by which osteopontin contributes to structural and electrical remodeling of the atria, to its potential as a biomarker for atrial fibrillation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteopontinAtrial FibrillationAtrial RemodelingHeart AtriaHumansAnimalsFibrosisBiomarkers

Stichwörter der Autor:innen

atrial fibrillationfibrosisosteopontin

Substanzen

OsteopontinBiomarkersSPP1 protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, Institute for Lung Health, Cardio-Pulmonary Institute, Member of the German Center for Lung Research Justus Liebig University of Giessen Giessen Germany.
  • Department of Cardiology University Hospital RWTH Aachen Aachen Germany.
  • Department of Mountain and Sleep Medicine and Pulmonary Hypertension, National Center of Cardiology and Internal Medicine Bishkek Kyrgyzstan.

ORCID-Profile: Balram Neupane, Akpay Sarybaev, Akylbek Sydykov, Ralph T Schermuly, Kabita Pradhan

Zitieren

APA

Mamazhakypov, A., Neupane, B., Sarybaev, A., Sydykov, A., Schermuly, R. T., Gramlich, M., & Pradhan, K. (2026). Osteopontin in Atrial Fibrillation and Atrial Remodeling. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.048418

Vancouver

Mamazhakypov A, Neupane B, Sarybaev A, Sydykov A, Schermuly RT, Gramlich M, et al. Osteopontin in Atrial Fibrillation and Atrial Remodeling. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.048418

BibTeX
@article{Mamazhakypov2026,
  author = {Mamazhakypov, Argen and Neupane, Balram and Sarybaev, Akpay and Sydykov, Akylbek and Schermuly, Ralph T and Gramlich, Michael and Pradhan, Kabita},
  title = {Osteopontin in Atrial Fibrillation and Atrial Remodeling},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.048418}
}
Kostenlos starten →